Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy

Abstract As cancer strikes, individuals vary not only in terms of factors that contribute to its occurrence and development, but as importantly, in their capacity to respond to treatment. While exciting new therapeutic options that mobilize the immune system against cancer have led to breakthroughs...

Full description

Bibliographic Details
Main Authors: Sacha Gnjatic, Vincenzo Bronte, Laura Rosa Brunet, Marcus O. Butler, Mary L. Disis, Jérôme Galon, Leif G. Hakansson, Brent A. Hanks, Vaios Karanikas, Samir N. Khleif, John M. Kirkwood, Lance D. Miller, Dolores J. Schendel, Isabelle Tanneau, Jon M. Wigginton, Lisa H. Butterfield
Format: Article
Language:English
Published: BMJ Publishing Group 2017-05-01
Series:Journal for ImmunoTherapy of Cancer
Subjects:
Cancer immunotherapy
Tumor microenvironment
Biomarkers
Baseline immunity
Immune checkpoint inhibitors
Online Access:http://link.springer.com/article/10.1186/s40425-017-0243-4

Internet

http://link.springer.com/article/10.1186/s40425-017-0243-4

Similar Items